Suppr超能文献

相似文献

1
A soluble α-synuclein construct forms a dynamic tetramer.
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17797-802. doi: 10.1073/pnas.1113260108. Epub 2011 Oct 17.
2
Explaining the structural plasticity of α-synuclein.
J Am Chem Soc. 2011 Dec 7;133(48):19536-46. doi: 10.1021/ja208657z. Epub 2011 Nov 14.
3
The dynamic structure of α-synuclein multimers.
J Am Chem Soc. 2013 Mar 13;135(10):3865-72. doi: 10.1021/ja310518p. Epub 2013 Feb 27.
4
The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
Biochemistry. 2007 Jun 19;46(24):7107-18. doi: 10.1021/bi7000246. Epub 2007 May 26.
5
Preparation and Characterization of Stable α-Synuclein Lipoprotein Particles.
J Biol Chem. 2016 Apr 15;291(16):8516-27. doi: 10.1074/jbc.M115.707968. Epub 2016 Feb 4.
10
Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.
J Mol Biol. 2009 Jul 24;390(4):775-90. doi: 10.1016/j.jmb.2009.05.066. Epub 2009 May 27.

引用本文的文献

1
Anion Binding and Aggregation of ‑Terminal α‑Synuclein Peptides.
ACS Omega. 2025 May 21;10(21):22216-22223. doi: 10.1021/acsomega.5c02618. eCollection 2025 Jun 3.
4
Lipidic folding pathway of α-Synuclein via a toxic oligomer.
Nat Commun. 2025 Jan 17;16(1):760. doi: 10.1038/s41467-025-55849-3.
5
Neuronal constitutive endolysosomal perforations enable α-synuclein aggregation by internalized PFFs.
J Cell Biol. 2025 Feb 3;224(2). doi: 10.1083/jcb.202401136. Epub 2024 Dec 23.
6
α-Synuclein pathology as a target in neurodegenerative diseases.
Nat Rev Neurol. 2025 Jan;21(1):32-47. doi: 10.1038/s41582-024-01043-w. Epub 2024 Nov 28.
7
Parkinson disease therapy: current strategies and future research priorities.
Nat Rev Neurol. 2024 Dec;20(12):695-707. doi: 10.1038/s41582-024-01034-x. Epub 2024 Nov 4.
8
Conformational Selection of α-Synuclein Tetramers at Biological Interfaces.
J Chem Inf Model. 2024 Oct 28;64(20):8010-8023. doi: 10.1021/acs.jcim.4c01459. Epub 2024 Oct 8.
9
Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models.
Mol Ther Nucleic Acids. 2024 Jun 15;35(3):102251. doi: 10.1016/j.omtn.2024.102251. eCollection 2024 Sep 10.
10
Folding of N-terminally acetylated α-synuclein upon interaction with lipid membranes.
Biophys J. 2024 Nov 5;123(21):3698-3720. doi: 10.1016/j.bpj.2024.09.019. Epub 2024 Sep 21.

本文引用的文献

1
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.
Nature. 2011 Aug 14;477(7362):107-10. doi: 10.1038/nature10324.
3
Mass estimation of native proteins by blue native electrophoresis: principles and practical hints.
Mol Cell Proteomics. 2010 Oct;9(10):2149-61. doi: 10.1074/mcp.M900526-MCP200. Epub 2010 Feb 20.
4
Structural properties of pore-forming oligomers of alpha-synuclein.
J Am Chem Soc. 2009 Dec 2;131(47):17482-9. doi: 10.1021/ja9077599.
5
Accurate random coil chemical shifts from an analysis of loop regions in native states of proteins.
J Am Chem Soc. 2009 Nov 18;131(45):16332-3. doi: 10.1021/ja904937a.
6
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.
EMBO J. 2009 Oct 21;28(20):3256-68. doi: 10.1038/emboj.2009.257. Epub 2009 Sep 10.
7
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts.
J Biomol NMR. 2009 Aug;44(4):213-23. doi: 10.1007/s10858-009-9333-z. Epub 2009 Jun 23.
9
Appion: an integrated, database-driven pipeline to facilitate EM image processing.
J Struct Biol. 2009 Apr;166(1):95-102. doi: 10.1016/j.jsb.2009.01.002.
10
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4635-40. doi: 10.1073/pnas.0806474106. Epub 2009 Mar 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验